http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.jpg 144 September 01, 2010 -- Nufarm Limited announced today that preliminary and unaudited analysis of 2010 year end results confirms that the net operating profit for the company will be within the $55... http://pharmalicensing.com/redirs/news_rss//public/news/view/530869/3/0/market-update http://pharmalicensing.com/redirs/news_rss//public/news/view/530869/3/0/market-update Marseilles, France, August 31, 2010 --Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) announces today its financial results for the first half of 2010. http://pharmalicensing.com/redirs/news_rss//public/news/view/530862/3/0/financial-results-for-the-first-half-of-2010-programs-on-track-decrease-in-operating-loss-controlled-burn-rate-and-strong-cash-position http://pharmalicensing.com/redirs/news_rss//public/news/view/530862/3/0/financial-results-for-the-first-half-of-2010-programs-on-track-decrease-in-operating-loss-controlled-burn-rate-and-strong-cash-position ST. LOUIS, August 31, 2010 -- As its fiscal year draws to a close, Monsanto Company (NYSE: MON) today confirmed the drivers of its fourth-quarter operating plan have tracked well with management... http://pharmalicensing.com/redirs/news_rss//public/news/view/530726/3/0/monsanto-projects-solid-conclusion-of-fiscal-year http://pharmalicensing.com/redirs/news_rss//public/news/view/530726/3/0/monsanto-projects-solid-conclusion-of-fiscal-year Vancouver, BC, Canada (August 30, 2010) - Pacgen Biopharmaceuticals Corporation ("Pacgen" or the "Company") (TSX-V: PGA) reported financial results from its first quarter ended June 30, 2010 ("Q1... http://pharmalicensing.com/redirs/news_rss//public/news/view/530894/3/0/pacgen-reports-first-quarter-financial-results http://pharmalicensing.com/redirs/news_rss//public/news/view/530894/3/0/pacgen-reports-first-quarter-financial-results August 30, 2010 -- During the first semester of 2010, turmoil was created in the Greek pharmaceutical market, in anticipation of price reductions which were announced by the government at the... http://pharmalicensing.com/redirs/news_rss//public/news/view/530748/3/0/financial-results-h1-2010 http://pharmalicensing.com/redirs/news_rss//public/news/view/530748/3/0/financial-results-h1-2010 27 August 2010 - Sydney, Australia, Auckland, New Zealand- Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) , a global company pioneering the development of cell implants to treat... http://pharmalicensing.com/redirs/news_rss//public/news/view/530875/3/0/preliminary-final-report-for-the-year-ended-30-june-2010 http://pharmalicensing.com/redirs/news_rss//public/news/view/530875/3/0/preliminary-final-report-for-the-year-ended-30-june-2010 Melbourne, Australia; 26 August 2010: Australia's regenerative medicine company, Mesoblast Limited (ASX: MSB; USOTC: MBLTY), today reported its results for the year ended 30 June 2010. http://pharmalicensing.com/redirs/news_rss//public/news/view/530714/3/0/mesoblast-financial-year-end-results http://pharmalicensing.com/redirs/news_rss//public/news/view/530714/3/0/mesoblast-financial-year-end-results ROCKVILLE, MD - August 16, 2010 - EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported financial results for... http://pharmalicensing.com/redirs/news_rss//public/news/view/530772/3/0/entremed-reports-second-quarter-2010-financial-results http://pharmalicensing.com/redirs/news_rss//public/news/view/530772/3/0/entremed-reports-second-quarter-2010-financial-results SOUTH SAN FRANCISCO, Calif., Aug 13, 2010 -- Hana Biosciences Inc. (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial... http://pharmalicensing.com/redirs/news_rss//public/news/view/530646/3/0/hana-biosciences-reports-second-quarter-2010-financial-results http://pharmalicensing.com/redirs/news_rss//public/news/view/530646/3/0/hana-biosciences-reports-second-quarter-2010-financial-results AUSTRALIA - 5th August 2010 - NuSep (ASX: NSP) wishes to advise the market that it will hold two investor presentations on 17th and 18th August 2010. These presentations will address the full year... http://pharmalicensing.com/redirs/news_rss//public/news/view/531045/3/0/nusep-investor-presentations http://pharmalicensing.com/redirs/news_rss//public/news/view/531045/3/0/nusep-investor-presentations